FDA Import Refusal 1FX-8265655-4/10002/2 — Rottendorf Pharma Gmbh
The FDA refused shipment 1FX-8265655-4/10002/2 from Rottendorf Pharma Gmbh (Germany) on Sep 14, 2026. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 14, 2026
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75